A: GLP-1 therapy is generally recommended for individuals who are obese (with a BMI of 30 or higher) or overweight (with a BMI of 27 or higher) with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Please keep in mind while your reimbursement rate is static for the course of your contract, whether or not the patient has coverage for these services is variable depending on their particular policy
Well, youll have the energy to actually enjoy all those outdoor activities were lucky to have year-round
Because most of it is lost to stomach enzymes, results take months to become visible
Other common symptoms include difficulty concentrating, memory problems, lightheadedness, or even shortness of breath with mild activity
See is compound tirzepatide safe